SD
Sanjana Devi Solanki
About Sanjana Devi Solanki
Data last updated:
Sanjana Devi Solanki is a Director at Genesia Pharmaceuticals (India) Private Limited (since 2012). The company operates in Pharma. Genesia Pharmaceuticals (India) Private Limited reported revenue of ₹6.51 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Nov 2012 | 2012 | ₹6.51 Cr (FY 2024) | Active |
Board colleagues of Sanjana Devi Solanki
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amar Chand Saini | 06424104 | Genesia Pharmaceuticals (India) Private Limited | Director |
| Avinash Agarwal | 06424110 | Genesia Pharmaceuticals (India) Private Limited | Director |
| Neena | 06424123 | Genesia Pharmaceuticals (India) Private Limited | Director |
| Pawan Kumar Mittal | 06424212 | Genesia Pharmaceuticals (India) Private Limited | Director |
| Rajeev Udawat | 06424217 | Genesia Pharmaceuticals (India) Private Limited | Director |
| Sheela Soni | 06424225 | Genesia Pharmaceuticals (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjana Devi Solanki
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjana Devi Solanki
Sanjana Devi Solanki currently holds 1 directorship: Genesia Pharmaceuticals (India) Private Limited (Director, since 27 Nov 2012, revenue ₹6.51 Cr (FY 2024)).
Sanjana Devi Solanki was first appointed on 27 Nov 2012 as Director at Genesia Pharmaceuticals (India) Private Limited.
The current boards of Sanjana Devi Solanki's companies include Amar Chand Saini (Genesia Pharmaceuticals (India) Private Limited), Avinash Agarwal (Genesia Pharmaceuticals (India) Private Limited), Neena (Genesia Pharmaceuticals (India) Private Limited), Pawan Kumar Mittal (Genesia Pharmaceuticals (India) Private Limited), Rajeev Udawat (Genesia Pharmaceuticals (India) Private Limited), Sheela Soni (Genesia Pharmaceuticals (India) Private Limited).